Galapagos (Netherlands) Performance
| GLPG Stock | EUR 26.14 0.32 1.21% |
The company retains a Market Volatility (i.e., Beta) of 0.94, which attests to possible diversification benefits within a given portfolio. Galapagos returns are very sensitive to returns on the market. As the market goes up or down, Galapagos is expected to follow. At this point, Galapagos NV has a negative expected return of -0.0036%. Please make sure to check out Galapagos' information ratio, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Galapagos NV performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Galapagos NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Galapagos is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 2.1 B | |
| Total Cashflows From Investing Activities | 541.2 M |
Galapagos |
Galapagos Relative Risk vs. Return Landscape
If you would invest 2,658 in Galapagos NV on August 31, 2024 and sell it today you would lose (44.00) from holding Galapagos NV or give up 1.66% of portfolio value over 90 days. Galapagos NV is generating negative expected returns and assumes 2.1462% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than Galapagos, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Galapagos Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Galapagos' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Galapagos NV, and traders can use it to determine the average amount a Galapagos' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0017
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GLPG |
Estimated Market Risk
| 2.15 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Galapagos is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Galapagos by adding Galapagos to a well-diversified portfolio.
Galapagos Fundamentals Growth
Galapagos Stock prices reflect investors' perceptions of the future prospects and financial health of Galapagos, and Galapagos fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Galapagos Stock performance.
| Return On Equity | 0.0021 | |||
| Return On Asset | -0.0119 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.17) % | |||
| Current Valuation | (2 B) | |||
| Shares Outstanding | 65.84 M | |||
| Price To Earning | (146.88) X | |||
| Price To Book | 0.87 X | |||
| Price To Sales | 4.37 X | |||
| Revenue | 484.85 M | |||
| EBITDA | (76.71 M) | |||
| Cash And Equivalents | 5.01 B | |||
| Cash Per Share | 76.41 X | |||
| Total Debt | 27.91 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 40.87 X | |||
| Cash Flow From Operations | (503.83 M) | |||
| Earnings Per Share | 0.08 X | |||
| Total Asset | 5.19 B | |||
About Galapagos Performance
Assessing Galapagos' fundamental ratios provides investors with valuable insights into Galapagos' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Galapagos is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. Galapagos NV was founded in 1999 and is headquartered in Mechelen, Belgium. GALAPAGOS operates under Biotechnology classification in Netherlands and is traded on Amsterdam Stock Exchange. It employs 1397 people.Things to note about Galapagos NV performance evaluation
Checking the ongoing alerts about Galapagos for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Galapagos NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Galapagos NV generated a negative expected return over the last 90 days | |
| The company reported the revenue of 484.85 M. Net Loss for the year was (103.23 M) with loss before overhead, payroll, taxes, and interest of (8.49 M). | |
| Galapagos NV has accumulated about 5.01 B in cash with (503.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 76.41, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 26.0% of the company shares are held by company insiders |
- Analyzing Galapagos' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Galapagos' stock is overvalued or undervalued compared to its peers.
- Examining Galapagos' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Galapagos' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Galapagos' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Galapagos' stock. These opinions can provide insight into Galapagos' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Galapagos Stock Analysis
When running Galapagos' price analysis, check to measure Galapagos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galapagos is operating at the current time. Most of Galapagos' value examination focuses on studying past and present price action to predict the probability of Galapagos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galapagos' price. Additionally, you may evaluate how the addition of Galapagos to your portfolios can decrease your overall portfolio volatility.